Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, Iran

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Abedi Ardekani, Behnoush ^a,b,c   Kamangar, Farin ^d,e   Sotoudeh, Masoud ^a   Villar, Stephanie ^b   Islami, Farhad ^a,b,f   Aghcheli, Karim ^a   Nasrollahzadeh, Dariush ^a,g   Taghavi, Noushin ^a   Dawsey, Sanford M ^d   Abnet, Christian C ^d   Hewitt, Stephen M ^d   Fahimi, Saman ^a,h   Saidi, Farrokh ^a   Brennan, Paul ^b   Boffetta, Paolo ^f,i   Malekzadeh, Reza ^a   Hainaut, Pierre ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Social Security Organization   (Iran)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MORGAN STATE UNIVERSITY   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MONOCLONAL ANTIBODY; OPIATE; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P53;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ETHNICITY; EXON; FEMALE; FLUID INTAKE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRAN; MAJOR CLINICAL STUDY; MALE; MUTAGENESIS; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TEA; TUMOR SUPPRESSOR GENE; URBAN RURAL DIFFERENCE; WATER TEMPERATURE; CODON; ESOPHAGUS TUMOR; GENETICS; MUTATION; RISK FACTOR;

AGED; CARCINOMA, SQUAMOUS CELL; CODON; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IRAN; MALE; MUTATION; RISK FACTORS;

EID: 84455172969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029488     Document Type: Article

References (37)

1. Eslick GD, (2009) Esophageal cancer: a historical perspective. Gastroenterol Clin North Am 38: 1-15, vii.
2. Kmet J, Mahboubi E, (1972) Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 175: 846-853.
3. Stewart BW, Kleihues P, (2003) Esophageal Cancer. World Cancer Report Lyon IARC press pp. 223-227.
4. Blot WJ, McLaughlin JK, Fraumeni JF, (2006) Esophageal Cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention Oxford Oxford University Press pp. 697-706.
5. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, et al. (2008) Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 98: 1857-1863.
6. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, et al. (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113: 456-463.
7. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, et al. (2009) Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 338: b929.
8. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. (2009) Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol 38: 978-988.
9. Kamangar F, Malekzadeh R, Dawsey SM, Saidi F, (2007) Esophageal cancer in Northeastern Iran: a review. Arch Iran Med 10: 70-82.
10. Olivier M, Hollstein M, Hainaut P, (2010) TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2: a001008.
11. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, et al. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21: 7435-7451.
12. Hainaut P, Pfeifer GP, (2001) Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 22: 367-374.
13. Smith LE, Denissenko MF, Bennett WP, Li H, Amin S, et al. (2000) Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst 92: 803-811.
14. Biramijamal F, Allameh A, Mirbod P, Groene HJ, Koomagi R, et al. (2001) Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. Cancer Res 61: 3119-3123.
15. Sepehr A, Taniere P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, et al. (2001) Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene 20: 7368-7374.
16. Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffetta P, et al. (2009) Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran- a review. Eur J Cancer 45: 3156-3165.
17. Gouas D, Shi H, Hainaut P, (2009) The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy. Cancer Lett 286: 29-37.
18. Taniere P, Martel-Planche G, Saurin JC, Lombard-Bohas C, Berger F, et al. (2001) TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer 85: 721-726.
19. Breton J, Sichel F, Abbas A, Marnay J, Arsene D, et al. (2003) Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France). Mutagenesis 18: 299-306.
20. Cao W, Chen X, Dai H, Wang H, Shen B, et al. (2004) Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China. Cancer 101: 834-844.
21. Putz A, Hartmann AA, Fontes PR, Alexandre CO, Silveira DA, et al. (2002) TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors. Int J Cancer 98: 99-105.
22. Rossini A, de Almeida ST, Marques CB, Soares-Lima SC, Herbster S, et al. (2010) TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil. Mutat Res 696: 10-15.
23. Cloutier JF, Drouin R, Weinfeld M, O'Connor TR, Castonguay A, (2001) Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA. J Mol Biol 313: 539-557.
24. Hakami R, Mohtadinia J, Etemadi A, Kamangar F, Nemati M, et al. (2008) Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer 60: 216-221.
25. Kamangar F, Strickland PT, Pourshams A, Malekzadeh R, Boffetta P, et al. (2005) High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res 25: 425-428.
26. Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, et al. (2010) Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut 59: 1178-1183.
27. Kazerouni N, Sinha R, Hsu CH, Greenberg A, Rothman N, (2001) Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 39: 423-436.
28. Chang KF, Fang GC, Chen JC, Wu YS, (2006) Atmospheric polycyclic aromatic hydrocarbons (PAHs) in Asia: a review from 1999 to 2004. Environ Pollut 142: 388-396.
29. Mastrangelo G, Fadda E, Marzia V, (1996) Polycyclic aromatic hydrocarbons and cancer in man. Environ Health Perspect 104: 1166-1170.
30. Straif K, Baan R, Grosse Y, Secretan B, El GF, et al. (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol 6: 931-932.
31. Friesen M, O'Neill IK, Malaveille C, Garren L, Hautefeuille A, et al. (1985) Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutat Res 150: 177-191.
32. Malaveille C, Friesen M, Camus AM, Garren L, Hautefeuille A, et al. (1982) Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus. Carcinogenesis 3: 577-585.
33. Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, et al. (2004) Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev 13: 1068-1070.
34. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, et al. (2009) High-temperature beverages and foods and esophageal cancer risk-a systematic review. Int J Cancer 125: 491-524.
35. Roth MJ, Strickland KL, Wang GQ, Rothman N, Greenberg A, et al. (1998) High levels of carcinogenic polycyclic aromatic hydrocarbons present within food from Linxian, China may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer 34: 757-758.
36. Lambert JM, Gorzov P, Veprintsev DB, Soderqvist M, Segerback D, et al. (2009) PRIMA-1 reactivates mutant p53 by covalent binding to the core domain 1. Cancer Cell 15: 376-388.
37. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, et al. (2004) Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 90: 1402-1406.